
Cover image

Volume 221, Issue 12, 15 June 2020
EDITORIAL COMMENTARIES
Human Immunodeficiency Virus, Antiretroviral Therapy, and Fertility in Sub-Saharan Africa: Pieces Still Missing in the Jigsaw Puzzle
Yellow Fever Vaccine: The Conundrum of 2 Doses, One Dose, or One-Fifth Dose to Induce and Maintain Protective Immunity
REVIEW
Association Between Maternal Human Papillomavirus Infection and Adverse Pregnancy Outcomes: Systematic Review and Meta-Analysis
This meta-analysis suggests that HPV is associated with preterm birth and preterm premature rupture of membranes. Associations are also possible for other adverse pregnancy outcomes, but the potential biases and the small number of studies do not allow definitive conclusions.
COVID PERSPECTIVE
My Future in Medicine: How COVID-19 Is Inspiring the Next Generation of Infectious Disease Specialists
MAJOR ARTICLES AND BRIEF REPORTS
COVID-2019
Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers
The asymptomatic SARS-CoV-2 carriers are important potential infection sources of COVID-19 and may have a long carrying period of SARS-CoV-2. Patients with normal chest CTs had a shorter period from diagnosis to being SARS-CoV-2-negative than those with typical CT changes.
Transmission Potential of Asymptomatic and Paucisymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections: A 3-Family Cluster Study in China
We report a unique 3-family cluster of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The transmission of SARS-CoV-2 by individuals with asymptomatic or paucisymptomatic infections likely occurred. SARS-CoV-2 was detected in contaminated environments of 1 household.
HIV/AIDS
Effect of HIV Infection and Antiretroviral Treatment on Pregnancy Rates in the Western Cape Province of South Africa
In South African women who have recently been pregnant, women who are human immunodeficiency virus (HIV) positive and receiving antiretroviral treatment have a higher pregnancy incidence rate than HIV-negative and untreated HIV-positive women.
Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2
This meta-analysis of HIV-2 protease, reverse transcriptase, and integrase mutations in sequences from antiretroviral naive and treated persons identified established and novel antiretroviral-selected mutations. These results will improve HIV-2 antiretroviral susceptibility prediction and prioritize HIV-2 resistance mutations for phenotypic studies.
Interstitial Lung Abnormalities in People With HIV Infection and Uninfected Controls
Interstitial lung abnormalities and findings suspicious for the presence of interstitial lung disease were more frequent in people with HIV infection compared to uninfected controls and were not explained by HIV-specific risk factors.
PATHOGENESIS AND HOST RESPONSE
Sensory Nociceptive Neurons Contribute to Host Protection During Enteric Infection With Citrobacter rodentium
Sensory neurons are important in coordinating the host mucosal immune response to the enteric bacterial pathogen Citrobacter rodentium.
Oncostatin M Is a Prognostic Biomarker and Inflammatory Mediator for Sepsis
OSM may represent a new biomarker for identification of septic patients with higher risk of mortality. Blocking OSM activity could reduce inflammation and tissue injury, thereby improving outcome. OSM might be a potential prognostic biomarker and therapeutic target for sepsis.
Neonatal BCG Vaccination Reduces Interferon-γ Responsiveness to Heterologous Pathogens in Infants From a Randomized Controlled Trial
Neonatal BCG vaccination results in a decreased proportion of infants mounting an IFN-γ response to heterologous stimulation at 7 months of age. Both sex and maternal BCG vaccination status influenced the effect of BCG vaccination on heterologous cytokine responses.
Dynamics of PfEMP1 Antibody Profile From Birth to 12 Months of Age in Beninese Infants
Analysis of the dynamics of anti-PfEMP1 IgG in a cohort of newborns in Benin showed acquisition of antibody to all types of CIDR domains at 12 months of age, with a significantly broader response in children with documented malaria infections.
VIRUSES
Persistence of Neutralizing Antibody Responses Among Yellow Fever Virus 17D Vaccinees Living in a Nonendemic Setting
Neutralizing antibody responses after single-dose vaccination with the yellow fever vaccine 17D remain high 0–3 years postvaccination but fall below a widely used neutralization threshold in a subset of vaccinees 3–12 years postvaccination.
Global Risk and Elimination of Yellow Fever Epidemics
We developed a model to evaluate the risk of urban yellow fever outbreaks. We found that the global risk of outbreaks is highly heterogeneous, and vaccination coverage needed to eliminate epidemics is higher than the recommended 80%, in many regions.
Evaluation of Genotypic Antiviral Resistance Testing as an Alternative to Phenotypic Testing in a Patient with DOCK8 Deficiency and Severe HSV-1 Disease
We show that genotypic antiviral resistance testing for HSV-1 can outperform phenotypic testing, which remains the clinical standard. We also demonstrate that HSV-1 can evolve rapidly in an immunocompromised host and that resistant HSV-1 can be transmitted between immunocompromised persons.
Time to Detection of Hepatitis C Virus Infection With the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis
Among people with detectable HCV RNA, median time to HCV RNA detection was 32 minutes with the Xpert HCV VL FS test. New strategies to reduce time to detection could reduce waiting times for HCV diagnosis, improving linkage to treatment.
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children
Live respiratory syncytial virus (RSV) vaccine D46/NS2/N/ΔM2-2-HindIII attenuated by deletion of the RSV RNA regulatory protein M2-2 had excellent infectivity and immunogenicity, and primed for anamnestic responses, encouraging further evaluation of this attenuation strategy.
FUNGI
Candida Species-Dependent Release of IL-12 by Dendritic Cells Induces Different Levels of NK Cell Stimulation
NK cells are integral part of antifungal immunity. Whereas Candida albicans is a stronger stimulus than Candida glabrata for human NK cells upon direct contact, only C. glabrata triggers strong indirect NK-cell activation in human blood via IL-12.
BACTERIA
Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion
Specific mutations in inhA, katG, and rpoB are associated with differences in resistance to other drugs and time-to-sputum-culture-conversion. Molecular testing may make it possible to tailor treatment and assess additional drug resistance risk according to specific mutation profile.